Vanguard Personalized Indexing Management, LLC Alx Oncology Holdings Inc Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.09 Billion
- Q3 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 28,657 shares of ALXO stock, worth $38,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,657Holding current value
$38,400% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALXO
# of Institutions
112Shares Held
41.5MCall Options Held
412KPut Options Held
142K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$13 Million33.06% of portfolio
-
Redmile Group, LLC San Francisco, CA4.04MShares$5.41 Million1.59% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.03MShares$5.41 Million1.07% of portfolio
-
Vestal Point Capital, LP New York, NY3.6MShares$4.82 Million1.62% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$3.6 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $54.6M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...